CGS-CIMB Research

Analysts trim estimates and TPs on FCT after 2HFY2023 and FY2023 results - THE EDGE SINGAPORE

Broker's Calls

Analysts trim estimates and TPs on FCT after 2HFY2023 and FY2023 results

The analysts' target prices range from $2.12 to $2.60.
DBS, UOBKH and CGS-CIMB analysts keep 'buy' and 'add' calls on MINT, while Citi and Maybank keep 'neutral' and 'hold' - THE EDGE SINGAPORE

Broker's Calls

DBS, UOBKH and CGS-CIMB analysts keep 'buy' and 'add' calls on MINT, while Citi and Maybank keep 'neutral' and 'hold'

This follows the REIT’s 2QFY2023/2024 ended Sept 30 results with “healthy gearing” and robust rental reversions, say analysts.
Maybank Securities maintains 'buy' call on FEHT on distribution stability and robust outlook - THE EDGE SINGAPORE

Broker's Calls

Maybank Securities maintains 'buy' call on FEHT on distribution stability and robust outlook

'FEHT offers a stable distribution profile and a lowly geared balance sheet'

Broker's Calls

Analysts remain positive on Keppel after 3QFY2023 business update; PhillipCapital upgrades to ‘buy’

The analysts from CGS-CIMB, DBS and PhillipCapital have target prices of $8.70, $8.05 and $7.52 respectively.
Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma - THE EDGE SINGAPORE

Broker's Calls

Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma

Although the incremental net profit contribution is likely negligible near term, the deal presents cross-selling opportunities.

Broker's Calls

CGS-CIMB lifts Frencken’s TP to $1.37 on improving outlook

Frencken is expected to release its 3QFY2023 update by Nov 27.

Broker's Calls

Brokers’ Digest: OCBC, Centurion, Frasers Property, Aztech Global, Sats, SIA

Here's what the analysts have to say this week.
Lady luck shall return, analysts keep 'buy' on Genting Singapore - THE EDGE SINGAPORE

Broker's Calls

Lady luck shall return, analysts keep 'buy' on Genting Singapore

UOBKH analyst believes Genting Singapore would deliver sequentially higher earnings q-o-q compared to MBS in 3QFY2023.

Investing ideas

Analysts positive on Keppel DC REIT after 3Q meets expectations

CGS-CIMB Research and DBS Group Research kept their "add" and "buy" calls while Citi and OCBC remained "neutral".
×